TickerFacts.

Adial Pharmaceuticals, Inc. (ADIL): Shareholders' Equity

Annual figures by period end, from SEC filings.

$5.28M
As of 2025-12-31
-$38.38M
As of 2026-06-30
+17.2%
3-year compound annual growth
+5.8%
5-year compound annual growth
$7.14M2017-12-31: -$997.6K2018-12-31: $4.44M2019-12-31: $7.14M2020-12-31: $3.99M2021-12-31: $3.51M2022-12-31: $3.28M2023-12-31: $4.08M2024-12-31: $4.07M2025-12-31: $5.28M$5.28M
2017-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$5.28M+29.7%2026-03-05, Balance as of period end
2024-12-31$4.07M-0.4%2026-03-05, Balance as of period end
2023-12-31$4.08M+24.6%2025-03-04, Balance as of period end
2022-12-31$3.28M-6.6%2024-04-01, Balance as of period end
2021-12-31$3.51M-12.0%2023-03-30, Balance as of period end
2020-12-31$3.99M-44.2%2022-03-28, Balance as of period end
2019-12-31$7.14M+60.8%2021-03-22, Balance as of period end
2018-12-31$4.44Mn/m2020-03-20, Balance as of period end
2017-12-31-$997.6Kn/a2019-02-19, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Adial Pharmaceuticals, Inc. (ADIL)2025-12-31$5.28M+29.7%
Kairos Pharma, Ltd. (KAPA)2025-12-31$6.34M+32.8%
OS Therapies Inc (OSTX)2025-12-31-$6.10Mn/m
Vyome Holdings, Inc (HIND)2025-12-31$3.76Mn/m
Serina Therapeutics, Inc. (SER)2025-12-31-$37.0Kn/m
CV Sciences, Inc. (CVSI)2025-12-31$1.47M-18.2%
Cannapharmarx, Inc. (CPMD)2025-12-31-$30.15Mn/m
GeoVax Labs, Inc. (GOVX)2025-12-31$3.83M-24.2%
Matinas BioPharma Holdings, Inc. (MTNB)2025-12-31$4.83M-36.4%

Compare ADIL, KAPA, OSTX, HIND side by side · Screen every company in Pharmaceutical Preparations ↗